We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Touts Personalized Medicine Model for Drug Development
FDA Touts Personalized Medicine Model for Drug Development
November 1, 2013
A new FDA report outlining the agency’s efforts to regulate drug development in the context of personalized medicine promotes the approach as a boon for both innovation and patient safety.